Inventor

MCSWIGGEN JAMES

US104 patents

⚠️ This page may combine multiple inventors who share the name “MCSWIGGEN JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MCSWIGGEN JAMES

RIBOZYME PHARM INC

HIV nef targeted ribozymes

Base-modified enzymatic nucleic acid

C-myb targeted ribozymes

Hairpin ribozymes

Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor

Ribozyme treatment of diseases or conditions related to levels of NF-κB

Nucleic acid based inhibition of CD40

B7-1 targeted ribozymes

Ribozymes targeted to APO(a) RNA

HIV targeted ribozymes

TNF-α ribozymes

Method of reducing stromelysin RNA via ribozymes

Base-modified enzymatic nucleic acid

IL-5 targeted ribozymes

Intercellular adhesion molecule-1 (ICAM-1) ribozymes

Stromelysin targeted ribozymes

Respiratory syncytial virus ribozymes

SIRNA THERAPEUTICS INC

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Nucleic acid molecules with novel chemical compositions capable of modulating gene expression

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

MCSWIGGEN JAMES

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)

BEIGELMAN LEONID

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

MERCK SHARP & DOHME

RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

TRANSLATE BIO MA INC

Compositions and methods for modulating ATP2A2 expression

Compositions and methods for modulating SMN gene family expression

RIBOZYME PHARMACEUTICAL INC

Hairpin ribozymes

CHIRON CORP

Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)

FEINSTEIN ELENA

Double-stranded RNA directed to CASP2 and methods of use thereof